Inogen | INGN - Current Assets


Inogen reported $203.72M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Abbott USD 26B 1.16B Dec/2025
Accuray USD 303.6M 13.86M Sep/2025
AngioDynamics USD 172.27M 3.09M Feb/2025
Artivion USD 337.5M 18.68M Sep/2025
AtriCure USD 322.52M 21.41M Dec/2025
Baxter International USD 6.87B 61M Dec/2025
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Boston Scientific USD 8.79B 759M Dec/2025
Chart Industries USD 2.9B 40.5M Dec/2025
Cooper Companies USD 2.11B 31.4M Sep/2025
Dexcom USD 4.03B 1.19B Dec/2025
Edwards Lifesciences USD 6.36B 218.3M Sep/2025
Globus Medical USD 2.13B 201.25M Dec/2025
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.91B 54.6M Dec/2025
Masimo USD 926M 122.3M Dec/2025
Medtronic USD 24B 773M Sep/2025
Orthofix International USD 394.17M 1.66M Sep/2025
Philips EUR 9.93B 654M Dec/2025
ResMed USD 3.82B 193.06M Dec/2025
Steris USD 2.29B 179.9M Dec/2025
Stryker USD 14.76B 1.04B Dec/2025
Tandem Diabetes Care USD 618.14M 1.2M Dec/2025
Teleflex USD 1.94B 47.65M Dec/2025
X T L Biopharmaceuticals USD 533K 807K Jun/2025
Zimmer Biomet Holdings USD 5.12B 715M Dec/2025